Resources
1. Sperling LC, Mezebish DS. Hair diseases. Med Clin North Am. 1998;82:1155–69.
2. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 3d ed. St. Louis: Mosby, 1996.
3. Sperling LC. Hair and systemic disease. Dermatol Clin. 2001;19:711–26.
4. Jackson EA. Hair disorders. Prim Care. 2000;27:319–32.
5. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol. 1996;35(3 pt 1):465–9.
6. Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin. 1998;16:341–56.
7. Sawaya ME, Shapiro J. Androgenetic alopecia. New approved and unapproved treatments. Dermatol Clin. 2000;18:47–61.
8. Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol. 1998;39(2 pt 3):S86–9.
9. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39(4 pt 1):578–89.
10. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41:550–4.
11. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, et al. Lack of efficacy of finasteride in post-menopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5 pt 1):768–76.
12. Goodheart HP. Hair and scalp disorders. Part 2: Alopecia areata. Womens Health Prim Care. 1999;2:283–7.
13. Bertolino AP. Alopecia areata. A clinical overview. Postgrad Med. 2000;107:81–5,89–90.
14. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549–66.
15. Messinger ML, Cheng TL. Trichotillomania. Pediatr Rev. 1999;20:249–50.
16. Rietschel RL. A simplified approach to the diagnosis of alopecia. Dermatol Clin. 1996;14:691–5.
17. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry. 1996;57(Suppl 8):42–7.
18. Alsafwah S, Alzein M. Small bowel obstruction due to trichobezoar: role of upper endoscopy in diagnosis. Gastroin-test Endosc. 2000;52:784–6.
19. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:539–42.
20. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol. 1999;40(6 Pt 2):S27–30.
21. Headington JT. Cicatricial alopecia. Dermatol Clin. 1996;14:773–82.
This article is one in a series coordinated by Daniel L. Stulberg, M.D., director of dermatology curriculum at the Utah Valley Family Practice Residency, Provo, Utah.
Types of Male Hair Loss
Prevention
Symptoms
Occurrence
Causes
Preparation for Medical Appointment
Support from Health Care Providers
Cultural Attitudes about Baldness
Psychological Implications
Career/Employment
Tests and Diagnosis
Treatment with Prescription Drugs
Surgical Procedures
Complications
Risk Factors and Warnings
Coping and Support
Resources
